| Literature DB >> 8290440 |
Abstract
Spironolactone therapy is a well-known cause of hyperkalaemia, but in susceptible patient, it may also be associated with metabolic acidosis. We report a case of severe renal tubular acidosis (Type IV) with life-threatening hyperkalaemia caused by spironolactone, and discuss the mechanisms by which this may occur.Entities:
Mesh：
Substances：
Year: 1993 PMID： 8290440 PMCID： PMC2399924 DOI： 10.1136/pgmj.69.817.887
Source DB: PubMed Journal: Postgrad Med J ISSN： 0032-5473 Impact factor: 2.401